Paola Barboro

11PUBLICATIONS
22CO-AUTHORS
Molecular targetsPredictive and prognostic markersCheminformatics and quantitative structure-activity relationshipsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 27, 2024
A Proteomics Approach Identifies RREB1 as a Crucial Molecular Target of Imidazo-Pyrazole Treatment in SKMEL-28 Melanoma Cells.

Erika Iervasi, Gabriela Coronel Vargas, Tiziana Bachetti

|Jan 23, 2024
Identification of Molecular Markers Associated with Prostate Cancer Subtypes: An Integrative Bioinformatics Approach.

Ilaria Granata, Paola Barboro

|Aug 17, 2022
Two calix[4]pyrroles as potential therapeutics for castration-resistant prostate cancer.

Imene Ben Toumia, Marco Ponassi, Paola Barboro

|Jun 21, 2022
The prognostic value of aspartate beta-hydroxylase in early breast cancer.

Paola Barboro, Alessandra Rubagotti, Silvia Poddine

|Oct 07, 2020
Epidemiological Characteristics and Survival in Patients with De Novo Metastatic Prostate Cancer.

Carlo Cattrini, Davide Soldato, Alessandra Rubagotti

|May 17, 2020
Erratum: Benelli, R., et al. Aspartate-β-Hydroxylase: A Promising Target to Limit the Local Invasiveness of Colorectal Cancer. Cancers 2020, 12, 971.

Roberto Benelli, Delfina Costa, Luca Mastracci

Pageof 2

Frequent Collaborators

4 joint publications

Nicoletta Ferrari

3 joint publications

Roberto Benelli

3 joint publications

Alessandro Poggi

2 joint publications

Camillo Rosano